New data for Roche’s Columvi and Lunsumio presented at ASH 2023 support continued benefit for people with lymphoma

Longer-term data from pivotal studies of fixed-duration Columvi and Lunsumio continue to show durable responses in people with heavily pre-treated lymphomas1,2 New data reinforce the potential of combination regimens in earlier treatment settings and add to the robust body of evidence supporting ongoing Phase III studies3,4,5,6 Basel, 11 December 2023 – Roche (SIX: RO, ROG;... Read more

New data reinforce the benefit of early preventative treatment with Roche’s Hemlibra for babies with severe haemophilia A

Phase III HAVEN 7 primary data presented at ASH 2023 provide additional confidence in the favourable efficacy and safety profile of subcutaneous Hemlibra given soon after birth 1 At nearly two years median follow-up in the descriptive, single-arm study, no babies experienced spontaneous bleeds requiring treatment, and all treated bleeds were as a result of... Read more

Combining a Small Instrument Size with the Highest Levels of Sensitivity in Their Class, and Featuring a Model Suitable for High-Temperature/High-Humidity RegionsNew Compact IRSpirit-X Series Fourier Transform Infrared Spectrophotometers

Combining a Small Instrument Size with the Highest Levels of Sensitivity in Their Class, and Featuring a Model Suitable for High-Temperature/High-Humidity RegionsNew Compact IRSpirit-X Series Fourier Transform Infrared Spectrophotometers Read more

Thermo Fisher Scientific Establishes 2030 Renewable Electricity Goal and Solar Power Purchase Agreement with ib vogt

Thermo Fisher Scientific Establishes 2030 Renewable Electricity Goal and Solar Power Purchase Agreement with ib vogt Share of 127-megawatt aggregated deal in collaboration with Eurofins Scientific will power over half of Thermo Fisher’s addressable European footprint with 100% renewable electricity by 2025 WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in... Read more

Thermo Fisher Scientific & Flagship Pioneering Expand Ongoing Strategic Partnership to Jointly Create New Platform Companies with First-in-Class Enabling Technologies for Life Sciences

Thermo Fisher Scientific & Flagship Pioneering Expand Ongoing Strategic Partnership to Jointly Create New Platform Companies with First-in-Class Enabling Technologies for Life Sciences WALTHAM, Mass. & CAMBRIDGE, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Flagship Pioneering, the bioplatform innovation company, today announced the formation of a strategic... Read more

JEOL E-Beam System Successfully Lands at Neighborhood 91: A New Chapter in Additive Manufacturing

Pittsburgh, PA | Oct 4, 2023– JEOL, a world-renowned leader in electron optics and advanced technology solutions, proudly announces the arrival of the JAM-5200EBM Electron Beam-Powder Bed Fusion system to Cumberland Additive located at Neighborhood 91, the advanced manufacturing production campus at Pittsburgh International Airport. JEOL’s leadership joined the Cumberland team this week to formally... Read more

Bruker Announces New Fraport AG Framework Contract for ETD Systems

Largest German airport FRA to modernize passenger security with up to 220 Bruker high-performance explosives trace detector (ETD) systems DE-tector™ flex FRANKFURT, Germany–(BUSINESS WIRE)– Fraport AG has announced the procurement decision in favor of Bruker for the provision of up to 220 DE-tector™ flex explosives and narcotics trace detectors to support their airport security measures.... Read more